Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium

L. A. Trissel, J. F. Martinez, Q. A. Xu

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The physical compatibility of fluorouracil mixed with leucovorin calcium or levoleucovorin calcium, undiluted and modestly diluted with 5% dextrose injection, was evaluated. Fluorouracil 50 mg/mL was combined in duplicate with leucovorin or levoleucovorin 20 mg/mL (as the calcium salt) in 250-mL polyvinyl chloride (PVC) portable-pump reservoirs in six volume ratios, either undiluted or diluted with 5% dextrose injection (to a final volume 25% greater than the drug volume). Duplicate reservoirs of each combination were stored for seven days at 4, 23, or 32 °C. Samples were evaluated visually with a high-intensity monodirectional light beam to observe development of particulates. Turbidimetry and light-obscuration particle counting and sizing also were used to evaluate compatibility. Small amounts of tiny crystalline particles developed in most of the combinations, usually by four days. In some cases, the particles could be seen in normal diffuse room light. Particle content was greater with higher leucovorin concentrations and over longer storage periods. Storage temperature did not play a consistent role in particle development. Fluorouracil and leucovorin calcium or levoleucovorin calcium were not compatible when stored in PVC reservoirs at 4, 23, or 32 °C.

Original languageEnglish (US)
Pages (from-to)710-715
Number of pages6
JournalAmerican Journal of Health-System Pharmacy
Volume52
Issue number7
DOIs
StatePublished - 1995

Keywords

  • Antineoplastic agents
  • Concentration
  • Containers
  • Devices
  • Dextrose
  • Fluorouracil
  • Incompatibiliti es
  • Injections
  • Leucovorin calcium
  • Levoleucovorin calcium
  • Polyvinyl chloride
  • Stability
  • Storage
  • Vehicles

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint

Dive into the research topics of 'Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium'. Together they form a unique fingerprint.

Cite this